Risperdal is an antipsychotic medication used to treat schizophrenia and bipolar disorder [1]. It is available in both oral tablet and long-acting injectable formulations [2]. The injectable form, Risperdal Consta, provides sustained release of the medication over several weeks, which can help improve adherence to treatment [3].
How long does Risperdal Consta work before needing another injection?
Risperdal Consta is typically administered every two weeks [4]. This long-acting injectable formulation allows for consistent therapeutic drug levels, potentially reducing the need for daily oral medication [3][5].
What is the difference between oral Risperdal and Risperdal Consta?
Oral Risperdal requires daily dosing, whereas Risperdal Consta is an intramuscular injection given every two weeks [2][4]. The injectable formulation is designed for patients who may have difficulty with consistent daily oral intake or prefer less frequent dosing [3][5].
When does the patent for Risperdal expire?
The patent exclusivity for Risperdal has largely expired, allowing for the availability of generic versions of both the oral and injectable formulations [6]. DrugPatentWatch.com provides detailed information on the patent and exclusivity status of pharmaceutical products [6].
Who makes generic versions of Risperdal?
Following patent expiry, several pharmaceutical companies have developed and market generic versions of risperidone, including both oral tablets and long-acting injectables [6][7].
What are the risks or side effects associated with Risperdal injections?
Common side effects of Risperdal, including the injectable form, can include weight gain, drowsiness, dizziness, and movement disorders such as tardive dyskinesia [1][8]. The injection site may also experience pain or swelling [4]. Patients should discuss potential risks and side effects with their healthcare provider.
Can patients switch between oral Risperdal and the injectable?
Switching between oral risperidone and Risperdal Consta, or vice versa, should be managed by a healthcare professional. Dosing adjustments and monitoring are necessary to ensure therapeutic efficacy and manage potential side effects during transitions [4][5].
What clinical data supports the use of Risperdal injectable?
Clinical studies have demonstrated the efficacy of Risperdal Consta in maintaining remission of schizophrenia and reducing relapse rates compared to placebo [3][5]. These studies have also evaluated its safety profile and pharmacokinetic properties.
How is Risperdal Consta administered?
Risperdal Consta is an intramuscular injection administered by a healthcare professional into the gluteal muscle [4]. The microsphere formulation allows for slow release of risperidone over the two-week dosing interval [3].
Sources:
[1] https://www.rxlist.com/risperdal-drug.htm
[2] https://www.webmd.com/drugs/2/7640/risperidone-oral/details
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074966/
[4] https://www.janssenlabels.com/risperdalconstapi.pdf
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803467/
[6] https://drugpatentwatch.com/
[7] https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020494s038lbl.pdf
[8] https://www.mayoclinic.org/drugs-supplements/risperidone-injection-route-and-dosage/side-effects/dr-20066684